MoonLake CFO Buys 354k Restricted Shares, Signaling Strong Insider Confidence and Future Growth
MoonLake CFO’s zero‑cost purchase of 354k restricted shares signals strong insider confidence ahead of its 2026 BLA filing, urging investors to reassess the high‑risk biotech’s value.
3 minutes to read